Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The Open Virology Journal|March 17, 2012
Adherence and Risk Behaviour in Patients with HIV Infection Receiving Antiretroviral Therapy in BangkokAmanda Clarke, Stephen Kerr, Adam Honeybrook, et al.
The Open Virology Journal|May 15, 2009
Supersensitive Viral Load Assay in Predicting CD4-Guided Treatment FailureSimone Langford, Angele Gayet-Ageron, Chris Duncombe, et al.
AIDS (London, England)|January 26, 2005
HIV disease progression in a patient cohort treated via a clinical research network in a resource limited settingChris Duncombe, Stephen J Kerr, Kiat Ruxrungtham, et al.
The Journal of Antimicrobial Chemotherapy|April 2, 2003
Pharmacokinetics and pharmacodynamics of indinavir with or without low-dose ritonavir in HIV-infected Thai patientsDavid Burger, Mark Boyd, Chris Duncombe, et al.
Asian Pacific Journal of Allergy and Immunology|October 31, 2002
Significant differences between plasma HIV-1 RNA assays in HIV-1 subtype E infected patients treated with antiretroviral therapyKiat Ruxrungtham, Sasiwimol Ubolyam, Elly A Hassink, et al.
Plos One|February 28, 2015
Differences in the direction of change of cerebral function parameters are evident over three years in HIV-infected individuals electively commencing initial cARTAlan Winston, Rebekah Puls, Stephen J Kerr, et al.
Neuroradiology|July 10, 2012
Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapyAlan Winston, Chris Duncombe, Patrick C K Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 12, 2010
Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled studyAlan Winston, Chris Duncombe, Patrick C K Li, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|March 3, 2007
Dyslipidemia in an Asian population after treatment for two years with protease inhibitor-containing regimensStephen J Kerr, Chris Duncombe, Anchalee Avihingsanon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 26, 2010
Efavirenz versus boosted atazanavir or zidovudine and abacavir in antiretroviral treatment-naive, HIV-infected subjects: week 48 data from the Altair studyRebekah L Puls, Preeyaporn Srasuebkul, Kathy Petoumenos, et al.
Pageof 3